Nicotinamide (Vitamin B3) to Prevent BCC/SCC: What the Evidence Says

Last updated: September 30, 2026

Quick Answer

Nicotinamide (vitamin B3) is an oral supplement shown in a large randomized trial to cut new non-melanoma skin cancers (basal cell carcinoma and squamous cell carcinoma) by roughly 23 percent over 12 months in people with a history of multiple skin cancers [1]. It is not a substitute for sunscreen or skin checks, works only while you keep taking it, and current 2026 guidance positions it as an optional add-on therapy for high-risk patients rather than a treatment for the general public.

Key Takeaways

• Nicotinamide (vitamin B3) reduced new non-melanoma skin cancers by about 23 percent in the ONTRAC trial, the largest study on this topic [1][2].
• The benefit applies to basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), not melanoma. No human evidence supports melanoma prevention [1][7].
• Protection is time-limited: benefits fade once you stop taking nicotinamide, so it is not a one-time fix [1].
• The standard studied dose is 500 mg twice daily, distinct from niacin, which causes flushing and is not interchangeable [1][3].
• Current expert guidance (January 2026) frames nicotinamide as an optional chemopreventive for selected high-risk patients, not a routine recommendation for everyone [5].
• A 2022 systematic review found benefit was confined to high-risk groups with no evidence supporting general population use [5].
• Nicotinamide has a favorable safety profile over 12 months of use, with good quality-of-life outcomes reported in trial participants [1][9].
• Evidence remains insufficient for organ transplant recipients and other immunosuppressed patients, despite their elevated skin cancer risk [7][9].
• Nicotinamide does not replace sunscreen or regular skin checks; it works alongside them, not instead of them.

What Is Nicotinamide and How Does It Work in the Body?

Nicotinamide is the amide form of vitamin B3, a water-soluble vitamin the body uses to make nicotinamide adenine dinucleotide (NAD), a molecule essential for cellular energy and DNA repair. In skin cancer prevention research, nicotinamide is studied specifically because ultraviolet (UV) light depletes cellular energy reserves needed to repair sun-damaged DNA, and nicotinamide appears to help restore that energy supply [7][9].

Sun exposure does two damaging things at once: it directly injures skin cell DNA, and it drains the ATP (cellular energy currency) that skin cells need to fix that damage. Laboratory research suggests nicotinamide helps offset this energy drain, giving skin cells more capacity to repair UV-induced DNA damage and maintain immune surveillance against abnormal cells before they turn into tumors [7].

Key points on how nicotinamide is thought to work:

• Restores cellular energy (ATP) that UV exposure depletes, supporting the machinery cells need for DNA repair [7].
• Supports DNA repair pathways in keratinocytes, the skin cells most often involved in BCC and SCC [9].
• Helps preserve immune function in skin that UV radiation otherwise suppresses, which matters because a weakened local immune response lets abnormal cells persist and grow [7].
• Does not reverse existing DNA mutations or treat existing cancers; it is a preventive measure, not a cure.

This is a mechanistic explanation supported by laboratory and preclinical research, not a guarantee of cancer prevention for any individual. It explains why researchers tested nicotinamide specifically in people already prone to sun-damage-related skin cancers.

Nicotinamide vs Niacinamide: Is There a Real Difference?

Nicotinamide and niacinamide are the same compound; niacinamide is simply the more common name used on supplement labels and skincare products. There is no chemical difference between them, so a bottle labeled "niacinamide" and one labeled "nicotinamide" contain the identical active ingredient.

Where confusion often happens is with niacin, a different form of vitamin B3 that is chemically distinct from nicotinamide/niacinamide.

CompoundAlso calledCommon useFlushing reactionNicotinamideNiacinamideSkin cancer prevention research, skincare, supplementsNoNiacinNicotinic acidCholesterol managementYes, often causes skin flushing

Decision rule: If a product label says "niacin" or "nicotinic acid," it is not the compound used in the skin cancer prevention studies discussed here. Only nicotinamide (niacinamide) has been tested in the major trials on BCC and SCC prevention [1][3]. Buying the wrong form will not deliver the studied benefit and may cause unwanted flushing instead.

Can Nicotinamide Prevent Skin Cancer? What the Studies Show

The strongest evidence comes from a single large randomized controlled trial, known as the ONTRAC study, which found that oral nicotinamide reduced new non-melanoma skin cancers by approximately 23 percent over 12 months compared with placebo in high-risk patients [1][2]. This is the core data point that shapes current clinical guidance on nicotinamide for skin cancer prevention.

The ONTRAC Trial and BCC/SCC Evidence

The ONTRAC trial enrolled patients with a history of at least two non-melanoma skin cancers in the previous five years, a group already known to be at high risk for developing more. Over 12 months, participants taking nicotinamide 500 mg twice daily had significantly fewer new basal cell carcinomas and squamous cell carcinomas compared to those on placebo [1][2]. Results from this trial were also presented at a major oncology conference, reinforcing its significance to the broader cancer research community [4][8].

A few things matter about how this trial was designed and what it actually tells us:

• Participants were not average members of the public; they already had a documented pattern of skin cancer recurrence, meaning the results describe a high-risk population, not everyone.
• The reduction applied to the combined total of new BCC and SCC cases, not to each type analyzed completely separately in isolation.
• The study measured outcomes over 12 months only, so it does not tell us what happens after 2, 5, or 10 years of continuous use.

Actinic Keratosis and Secondary Benefits

Nicotinamide also reduced the number of actinic keratoses (AKs), the rough, scaly precancerous skin patches that can sometimes progress to squamous cell carcinoma, though this was a secondary finding rather than the trial's main measured outcome [1]. AK reduction matters clinically because fewer precancerous lesions generally means fewer opportunities for those lesions to progress into invasive skin cancer over time.

Edge case: Nicotinamide reducing AK count is a supportive, secondary benefit. It should not be mistaken for a treatment that clears existing AKs the way cryotherapy or topical prescription creams do. If you already have diagnosed actinic keratoses, talk to your provider about direct treatment options such as cryotherapy for mole and lesion removal, rather than relying on nicotinamide alone to resolve them.

Does Nicotinamide Prevent Melanoma?

No. There is no human clinical trial evidence that nicotinamide prevents melanoma; the only supportive data comes from preclinical (laboratory and animal) studies, not from trials in people [7]. Melanoma has a different biology from BCC and SCC, and the ONTRAC trial specifically measured non-melanoma skin cancers, so its results cannot be extended to melanoma risk.

Common mistake: Assuming nicotinamide protects against all types of skin cancer, including melanoma, because it works for BCC and SCC. This is incorrect and could lead someone to skip mole checks or delay seeing a doctor about a changing mole. Anyone monitoring for melanoma should understand the difference between BCC and SCC and recognize that melanoma surveillance requires separate, dedicated skin checks regardless of nicotinamide use.

Nicotinamide Dosage for Skin Cancer Prevention

The dose used in the pivotal ONTRAC trial, and the dose most commonly referenced in clinical guidance, is 500 mg of nicotinamide taken twice daily, for a total of 1,000 mg per day [1]. This dosing schedule is the only one with strong trial-level evidence behind it for skin cancer prevention specifically.

Practical points on dosing:

• Total daily dose: 1,000 mg, split into two 500 mg doses rather than one large dose.
• Timing: The trial did not require dosing at specific times relative to meals; consistency day to day matters more than exact timing.
• Formulation: Standard oral nicotinamide tablets or capsules, not topical nicotinamide/niacinamide skincare products, which have not been tested for this systemic cancer-prevention effect.
• Duration studied: 12 continuous months in the main trial; longer-term dosing schedules beyond that have less direct trial evidence.

Choose this dose if: you have a documented history of multiple BCC or SCC diagnoses and your dermatologist has discussed nicotinamide as an adjunct strategy. Do not self-prescribe a higher dose assuming "more is better." No trial evidence supports doses above 1,000 mg daily for cancer prevention, and higher doses increase the chance of side effects without added proven benefit.

Nicotinamide Side Effects and Safety (Including Long-Term Use)

Nicotinamide at the studied dose of 1,000 mg daily was generally well tolerated over the 12-month trial period, with quality-of-life measures remaining stable among participants [1][9]. This makes it one of the better-tolerated chemopreventive options studied for skin cancer, compared to some topical or systemic alternatives.

Reported safety characteristics include:

• No significant flushing reaction, unlike niacin, because nicotinamide does not trigger the same vasodilation response.
• Generally mild or no side effects reported in trial participants at the standard dose [1].
• No significant drug interactions flagged in the core trial data, though anyone on multiple medications should still review supplements with a pharmacist or physician.
• Good tolerability over the study duration, supporting its use as a daily long-term supplement rather than a short course [9].

Is Nicotinamide Safe to Take Long Term?

The 12-month trial data supports good short-to-medium-term safety, but formal long-term safety data extending well beyond one year of continuous daily use is more limited [1][9]. This is an important distinction: "safe for 12 months in a trial" is not automatically the same as "proven safe for 10 years of continuous use."

Decision rule: If your dermatologist recommends nicotinamide because of your high-risk history, plan for periodic check-ins, at least annually, to reassess whether continued use still makes sense, rather than starting it once and never revisiting the decision. This mirrors the general principle of ongoing monitoring covered in evidence-based recommendations for a skin-healthy lifestyle, where consistent long-term habits matter more than any single intervention.

Who Should Take Nicotinamide for Skin Protection?

Nicotinamide is best suited for people with a documented history of multiple non-melanoma skin cancers, meaning at least two prior BCC or SCC diagnoses, who are considered high-risk for developing more. It is not currently recommended as a general preventive supplement for the average adult with normal skin cancer risk.

Good candidates typically share these features:

• History of two or more basal cell carcinomas or squamous cell carcinomas.
• Ongoing dermatology follow-up already in place for skin monitoring.
• Willingness to take a daily oral supplement consistently for at least 12 months.
• Understanding that nicotinamide is an add-on, not a replacement for sun protection or skin exams.

Groups where evidence is less clear or insufficient:

• General population with no personal history of skin cancer: a 2022 systematic review found the benefit was confined to high-risk groups, with no evidence supporting routine use in people without that history [5].
• Organ transplant recipients and immunosuppressed patients, who face elevated skin cancer risk due to immunosuppressive medications, but for whom current evidence remains insufficient to confirm the same protective effect seen in the general high-risk trial population [7][9].

Nicotinamide for Fair Skin vs Dark Skin: Does Effectiveness Differ?

The core trial evidence for nicotinamide comes primarily from studies of people with fair skin and a history of significant UV-related skin cancer, so direct evidence in people with darker skin tones is limited. This does not mean nicotinamide fails to work in people with darker skin; it means the specific, high-quality trial data is concentrated in the population most affected by UV-driven BCC and SCC, which tends to be fair-skinned individuals with extensive sun exposure history.

Practical takeaway: Skin cancer risk factors and prevention strategies should always be individualized. Regardless of skin tone, anyone with a personal or family history of skin cancer benefits from routine professional skin checks. A mole check and skin exam can help establish your individual risk profile and determine whether nicotinamide or other preventive strategies make sense for you specifically.

Nicotinamide vs Sunscreen: Which Is Better, or Do You Need Both?

Sunscreen and nicotinamide are not competing options; they work through different mechanisms and address different parts of skin cancer risk, so current guidance treats them as complementary rather than as alternatives to each other. Sunscreen blocks UV radiation before it reaches skin cells, while nicotinamide works inside cells to support DNA repair after some UV exposure has already occurred.

FactorSunscreenNicotinamideHow it worksBlocks/reflects UV before skin exposureSupports DNA repair after cell exposureEvidence strengthStrong, decades of researchModerate, one major trial [1]Melanoma protectionYes, establishedNo evidence in humans [7]Who it is forEveryoneHigh-risk BCC/SCC history mainly [5]Effect after stoppingProtection only while appliedBenefit fades after stopping [1]

Choose sunscreen as your foundation, always. Add nicotinamide on top of sunscreen use, not instead of it, if your dermatologist confirms you fit the high-risk profile the trial evidence supports. Neither one alone is a complete skin cancer prevention plan; they address different stages of sun damage.

How Long Does Nicotinamide Take to Work, and What If It Is Not Working?

Based on trial data, nicotinamide's protective effect on new skin cancer formation was measured over a full 12-month period, meaning meaningful risk reduction is a cumulative effect over months, not something noticeable within days or weeks. There is no fast, visible sign that "it's working," because the benefit is statistical (fewer new cancers over time), not a symptom you can feel or see immediately.

Realistic expectations:

• No immediate skin change should be expected in the first few weeks.
• Benefit builds over months as cumulative UV-repair support and reduced cancer formation add up across the full study period.
• Protection is not permanent: the trial evidence indicates the effect wanes once nicotinamide is stopped, meaning it needs to be taken continuously to keep working [1].

What to Do If Nicotinamide Does Not Seem to Be Working

If you continue developing new BCC or SCC lesions while taking nicotinamide, this does not necessarily mean the supplement has failed; it means nicotinamide only reduced average risk by about 23 percent in trials, it did not eliminate risk entirely [1]. A meaningful risk reduction still leaves room for new lesions to occur, especially in people with a heavy prior history of skin cancer.

Steps to take if you develop a new suspicious spot while on nicotinamide:

1. Do not stop dermatology follow-up. Continue scheduled skin checks regardless of how long you have been taking nicotinamide.
2. Get any new or changing lesion evaluated promptly, rather than waiting, since early detection and treatment remain the most important factor in outcomes.
3. Review adherence with your provider; missed doses or inconsistent use can reduce whatever benefit nicotinamide might otherwise provide.
4. Reassess other risk factors, including sun exposure habits, since nicotinamide is only one part of a broader prevention strategy alongside diet and lifestyle, as outlined in guidance on nutrition and skin health.
5. Discuss next steps for treatment if a new BCC or SCC is confirmed; understanding what recovery after basal cell carcinoma removal looks like can help you prepare.

Common mistake: Stopping nicotinamide abruptly after a new diagnosis, assuming it is useless. A single new lesion does not cancel out a statistically meaningful average risk reduction across a whole treatment population; discuss any changes to your regimen with your prescribing clinician rather than stopping on your own.

Best Nicotinamide Supplements and Where to Get It

Nicotinamide (also sold as niacinamide) is available over the counter as a standard oral vitamin supplement in most pharmacies and health stores, and it does not require a prescription in most regions, though a doctor's guidance on dosing for skin cancer prevention specifically is strongly recommended. Because it is sold as a general-purpose vitamin, label quality and dose accuracy vary, so a few practical checks matter before choosing a product.

What to check when choosing a nicotinamide supplement:

• Confirm the label says "nicotinamide" or "niacinamide," not "niacin" or "nicotinic acid," since only the former matches the studied compound.
• Check the per-tablet dose. Many standard supplements come in 500 mg tablets, matching the trial's twice-daily protocol; verify this against the label rather than assuming.
• Look for third-party testing or quality seals where available, since supplement manufacturing is less tightly regulated than prescription medication.
• Avoid products bundled with high doses of other active ingredients unless your doctor specifically recommends a combination formula; simple, single-ingredient nicotinamide is easiest to dose accurately.

Prescription vs over-the-counter: In practice, most patients obtain nicotinamide over the counter after a discussion with their dermatologist, rather than through a formal prescription, since it is classified as a vitamin supplement in most jurisdictions rather than a regulated drug. Even though a prescription typically is not required, treat the decision to start nicotinamide as a medical one. Bring it up during a regular dermatology visit or mole and skin check so your provider can confirm you fit the high-risk profile the evidence supports and rule out any reason it might not be appropriate for you.

What the Latest 2026 Guidance Says

As of January 2026, comprehensive clinical guidance frames nicotinamide as an optional chemopreventive option for carefully selected high-risk patients, not a first-line or universal recommendation [5]. This represents a cautious, evidence-anchored position rather than broad endorsement.

"The overall 2026 consensus treats nicotinamide as a modest, evidence-based adjunct, not a stand-alone solution for skin cancer prevention."

Supporting context behind this cautious stance:

• Public health commentary from cancer research organizations has offered cautious endorsement limited to very high-risk patients, reflecting the same population studied in the original trial, rather than the public at large [8].
• Patient willingness data suggests that when people understand the actual size of the benefit (roughly 23 percent reduction, not elimination of risk), most still consider the risk-benefit trade-off favorable given the low side-effect burden [6].
• The evidence base has not meaningfully expanded to new populations, such as transplant recipients, since the original trial, which keeps guidance conservative for those groups [7][9].

Bottom line for 2026: Nicotinamide occupies a specific, well-defined niche. It is a reasonable, low-risk addition for people with a proven pattern of recurrent non-melanoma skin cancer, used alongside (never instead of) sunscreen, protective clothing, and regular skin checks.

Frequently Asked Questions

Does nicotinamide really prevent skin cancer?
Nicotinamide reduced new basal cell carcinoma and squamous cell carcinoma cases by about 23 percent over 12 months in a high-risk population in the ONTRAC trial [1]. It lowers risk; it does not eliminate it or guarantee prevention for any individual person.

Is niacinamide the same as nicotinamide for skin cancer prevention?
Yes, niacinamide and nicotinamide are the same compound, just different names for the identical active ingredient [3]. Niacin (nicotinic acid) is a different compound and has not been tested for this benefit.

What is the correct nicotinamide dose for skin cancer prevention?
The dose used in the pivotal clinical trial was 500 mg taken twice daily, for a total of 1,000 mg per day [1]. This is the only dosing schedule with strong trial evidence behind it.

Can I take nicotinamide instead of wearing sunscreen?
No. Nicotinamide works inside skin cells after UV exposure has occurred, while sunscreen blocks UV exposure before it happens; they serve different, complementary roles and neither replaces the other.

Does nicotinamide prevent melanoma?
No human trial evidence supports melanoma prevention with nicotinamide; only preclinical laboratory data exists, and melanoma requires its own separate monitoring and prevention approach [7].

How long do I need to take nicotinamide before it works?
Trial-measured benefits accumulated over a full 12-month period. There is no immediate or visible sign of benefit; risk reduction is a statistical, long-term effect, not something felt in days or weeks [1].

What happens if I stop taking nicotinamide?
Protective benefit appears to fade once nicotinamide is discontinued, based on trial evidence, meaning continuous daily use is needed to maintain the effect [1].

Is nicotinamide safe for long-term daily use?
It was well tolerated over the 12-month trial period with stable quality-of-life outcomes [1][9]. Data on continuous use beyond that timeframe is more limited, so periodic medical review is advised.

Who should not bother taking nicotinamide?
People with no personal history of skin cancer and average population risk are not currently supported by evidence for routine nicotinamide use; benefit has only been clearly shown in high-risk groups with prior BCC or SCC history [5].

Can organ transplant patients take nicotinamide for skin cancer prevention?
Evidence in transplant recipients and other immunosuppressed patients remains insufficient to confirm the same benefit seen in the general high-risk trial population, so this should be discussed individually with a transplant dermatology team [7][9].

Do I need a prescription to buy nicotinamide?
In most regions, nicotinamide (niacinamide) is available over the counter as a vitamin supplement without a prescription, though discussing the decision with a dermatologist first is strongly recommended to confirm it fits your risk profile.

Where can I learn more about the difference between BCC and SCC?
Basal cell carcinoma and squamous cell carcinoma are both non-melanoma skin cancers but differ in behavior and risk; see a detailed breakdown of how BCC and SCC differ for a fuller comparison.

Conclusion

Nicotinamide (vitamin B3) has real, trial-backed evidence behind it, but that evidence points to a specific, limited role rather than a broad cure-all. The ONTRAC trial showed a roughly 23 percent reduction in new non-melanoma skin cancers among high-risk patients over 12 months, a meaningful but modest effect that fades once the supplement is stopped [1]. It works well alongside sunscreen and regular skin checks, not as a substitute for either.

If you have a history of two or more basal cell carcinomas or squamous cell carcinomas, nicotinamide is worth discussing with your dermatologist as a low-risk, well-tolerated add-on to your existing prevention plan. If you have no personal history of skin cancer, current evidence does not support starting it just as a precaution.

Practical next steps:

1. Review your personal skin cancer history with a dermatologist to determine if you fit the high-risk profile the trial evidence supports.
2. If appropriate, start nicotinamide at the studied dose of 500 mg twice daily, and commit to consistent daily use, since stopping reverses the benefit.
3. Keep sunscreen, protective clothing, and shade-seeking habits as your primary defense, never a secondary one.
4. Maintain scheduled skin checks regardless of whether you start nicotinamide, since it reduces average risk but does not eliminate the need for early detection.
5. Reassess the decision periodically with your provider rather than treating it as a permanent, one-time choice.

References

[1] Nejmoa1506197 - https://www.nejm.org/doi/full/10.1056/NEJMoa1506197
[2] Nejmoa1506197 - https://www.augusta.edu/cancer/community/teledermatology-program/documents/nejmoa1506197.pdf
[3] Phpp - https://onlinelibrary.wiley.com/doi/full/10.1111/phpp.12328
[4] Jco.2015.33.15 Suppl - https://ascopubs.org/doi/10.1200/jco.2015.33.15_suppl.9000
[5] academic.oup - https://academic.oup.com/ced/article/42/8/945/6623275?searchresult=1
[6] Pmc10050186 - https://pmc.ncbi.nlm.nih.gov/articles/PMC10050186/
[7] Pmc4570055 - https://pmc.ncbi.nlm.nih.gov/articles/PMC4570055/
[8] Simple Means Of Preventing Nonmelanoma Skin Cancer Reported - https://ascopost.com/issues/may-25-2015/simple-means-of-preventing-nonmelanoma-skin-cancer-reported/
[9] Pmc6473406 - https://pmc.ncbi.nlm.nih.gov/articles/PMC6473406/
[10] 09546634.2023 - https://www.tandfonline.com/doi/full/10.1080/09546634.2023.2247105

‍